Healio

First-in-class enpatoran demonstrates improvement over placebo in cutaneous lupus

Please provide your email address to receive an email when new articles are posted on . Enpatoran bested placebo in CLASI-50 and CLASI-70 at 16 and 24 weeks. The oral small molecule toll-like receptor ...
The New England Journal of Medicine

Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus

Blood dendritic cell antigen 2 (BDCA2) is a receptor that is exclusively expressed on plasmacytoid dendritic cells, which are implicated in the pathogenesis of lupus erythematosus. Whether treatment ...
Healio

Topical gel shows promise in treating cutaneous events from EGFR inhibitor cancer therapy

Please provide your email address to receive an email when new articles are posted on . Phase 2a interim data show 100% of patients achieving the primary endpoint of skin toxicity improvement. Also, ...
News Medical

Bovine H5N1 influenza shows potential for human adaptation through key mutations

Study reveals how specific mutations in the H5N1 virus enhance its ability to bind human receptors, underscoring the need for ongoing surveillance of emerging strains. Study: A single mutation in ...